The store will not work correctly when cookies are disabled.
1-[2-(5-Methyl-pyridin-2-ylmethanesulfinyl)-3H-thieno[3,4-d]imidazol-6-yl]-ethanone
ID: ALA140420
PubChem CID: 15133692
Max Phase: Preclinical
Molecular Formula: C14H13N3O2S2
Molecular Weight: 319.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)c1scc2[nH]c([S+]([O-])Cc3ccc(C)cn3)nc12
Standard InChI: InChI=1S/C14H13N3O2S2/c1-8-3-4-10(15-5-8)7-21(19)14-16-11-6-20-13(9(2)18)12(11)17-14/h3-6H,7H2,1-2H3,(H,16,17)
Standard InChI Key: FVWWJIDZVRWKPA-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
6.3866 -3.8253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5660 -3.9594 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1883 -3.2144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5158 -3.0093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1204 -4.1996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7786 -2.6301 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7100 -3.6195 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.3680 -3.0845 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.3350 -2.8834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5875 -3.3748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2448 -5.0271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1007 -2.0267 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5187 -2.2680 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9542 -2.8439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5987 -5.5418 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4542 -1.4976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6786 -1.7846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1779 -3.1350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5389 -2.6116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0182 -5.3233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0404 -1.2570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 1 1 0
5 1 2 0
6 4 1 0
7 5 1 0
8 3 1 0
9 4 2 0
10 8 1 0
11 5 1 0
12 14 2 0
13 8 1 0
14 10 1 0
15 11 2 0
16 12 1 0
17 19 1 0
18 14 1 0
19 18 2 0
20 11 1 0
21 17 1 0
7 9 1 0
6 3 1 0
16 17 2 0
M CHG 2 8 1 13 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 319.41 | Molecular Weight (Monoisotopic): 319.0449 | AlogP: 2.84 | #Rotatable Bonds: 4 |
Polar Surface Area: 81.70 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.83 | CX Basic pKa: 2.87 | CX LogP: 1.71 | CX LogD: 1.59 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.59 | Np Likeness Score: -0.98 |
References
1. Weidmann K, Herling AW, Lang HJ, Scheunemann KH, Rippel R, Nimmesgern H, Scholl T, Bickel M, Metzger H.. (1992) 2-[(2-pyridylmethyl)sulfinyl]-1H-thieno[3,4-d]imidazoles. A novel class of gastric H+/K(+)-ATPase inhibitors., 35 (3): [PMID:1310742] [10.1021/jm00081a004] |